Lakewood-Amedex Biotherapeutics（LABT.US）股東結構 - 機構持倉、大股東與內部人士｜長橋證券

股東類型

個人與內幕人士44.30%
公眾及其他38.25%
私人企業12.01%
機構投資者5.44%

主要股東

主要股東最新
股東
Steve ParkinsonFormer CEO, President & Executive Director	19.69%	46.66 萬	47.01%	+0	09/10/2025
Thomas Kaufmann	14.50%	34.36 萬	1.34%	+1.00	16/09/2026
Lindesfarne LLC	9.75%	23.10 萬	0.37%	+2.76 萬	16/09/2026
Royal Caswell	5.32%	12.60 萬	0.49%	+1.00	16/09/2026
TLP Management, LP	3.29%	7.80 萬	--	+7.80 萬	23/04/2026
Ted BrownFormer Non-Executive Director	3.27%	7.75 萬	107.58%	-69.79 萬	23/04/2026
Marex Group Limited	2.03%	4.82 萬	--	+4.82 萬	30/06/2026
Hudson River Trading LLC	1.89%	4.48 萬	--	+4.48 萬	30/06/2026
Bortel Investment Management, LLC	1.19%	2.82 萬	2.84%	+0	09/10/2025
Peter CeccacciCFO & VP of Administration	0.47%	1.11 萬	0.04%	+1.00	16/09/2026
Leonard DeromaIndependent Director	0.31%	7,457.00	0.03%	+1.00	16/09/2026
Douglas ManionIndependent Chairman	0.22%	5,181.00	0.02%	+1.00	16/09/2026
UBS Asset Management AG	0.17%	4,098.00	--	+4,098.00	30/06/2026
Geode Capital Management, LLC	0.06%	1,493.00	<0.01%	+0	31/07/2026
Tower Research Capital Europe Limited	0.03%	624.00	--	+624.00	30/06/2026
Osaic Wealth, Inc.	<0.01%	138.00	--	+138.00	30/06/2026
Thrivent Trust Co.	<0.01%	11.00	--	+11.00	30/06/2026
Kelvin CooperCEO, SVP of Research & Development and Director	0.00%	0.00	0.00%	+0	23/04/2026
Thomas BalzerChief Medical Officer & SVP of Clinical Development	0.00%	0.00	0.00%	+0	23/04/2026